Modern molecular direct tests for rapid identification and drug susceptibility testing of Mycobacterium tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012
First experience with novel molecular diagnostic method for detection of M. tuberculosis and rifampicin resistance Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Source: International Congress 2015 – Science and biomarkers in TB Year: 2015
Current and emerging approaches to the genetic diagnosis of chILDs Source: International Congress 2014 – Interstitial lung disease (ILD) in children Year: 2014
Treatment of migrants with tuberculosis in an era of emerging drug resistance Source: Annual Congress 2010 - Tuberculosis drug resistance and migration Year: 2010
When will genetic testing replace standard drug susceptibility testing? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018
MDR-TB: from epidemiology to treatment design Source: Annual Congress 2011 - PG12 TB-PAN-NET Multidrug-resistant and extensively drug-resistant tuberculosis: update on clinical management Year: 2011
Impact of phenotyping upon treatment choices in childhood Source: Annual Congress 2010 - A new understanding of childhood wheeze phenotypes Year: 2010
Molecular epidemiology, drug resistance, and treatment of tuberculosis in Germany: preliminary results Source: Eur Respir J 2003; 22: Suppl. 45, 485s Year: 2003
Phenotypic fingerprinting of disease through biomarker profiling Source: Annual Congress 2010 - New tools for the trade: novel emerging technologies to assess lung development and disease Year: 2010
Multidimensional approaches to asthma: the need to look beyond drug treatments Source: Annual Congress 2010 - Breathing therapies for asthma Year: 2010
Efficiency of molecular methods for epidemiological investigation in tuberculosis (TB) Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012
Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance Source: Eur Respir J 2007; 30: Suppl. 51, 203s Year: 2007
Usefulness of a new molecular method to detect fluoroquinolones, kanamycin, capreomycin and ethambutol resistance in TB clinical isolates and direct specimens Source: Annual Congress 2010 - Tuberculosis: from bench to bedside Year: 2010
Unifying candidate gene and GWAS approaches in asthma Source: Annual Congress 2010 - Genetics of asthma Year: 2010
Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods Source: Eur Respir J, 51 (5) 1702189; 10.1183/13993003.02189-2017 Year: 2018
Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens Source: Eur Respir J, 50 (6) 1702292; 10.1183/13993003.02292-2017 Year: 2017
Improved diagnostics and diagnostic approaches: The role in the fight to emerging infectious diseases (EID) and antimicrobial resistance (AMR) Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021